Michael Rosenblatt

Michael Rosenblatt

Direttore/Membro del Consiglio presso PYC THERAPEUTICS LIMITED

Patrimonio netto: 704 920 $ in data 31/01/2025

77 anni
Health Technology
Health Services
Consumer Services

Profilo

Michael A.
Rosenblatt
was the founder of Theracrine, Inc. (2006) and Radius Health, Inc. (2003) with the title of Director.
Current jobs include Non-Executive Director at PYC Therapeutics Ltd.
(2021), Director at Ferring Pharmaceuticals, Inc. (2016), Non-Executive Director at Perspectum Ltd., Director at Ohana Biosciences, Inc. (2016), Director at Cygnal Therapeutics, Inc. (2016), Director at Perspectum Group Ltd.
(2022), Senior Advisor at Flagship Pioneering, Inc. (2022), and Advisor at PureTech Health LLC.
Former jobs include Non-Executive Director at Shire Plc (2008), Non-Executive Director at Shire Plc (2008-2009), Director at ProScript, Inc., Director at Project HOPE-The-People-To-People Health Foundation, Inc., Director at Harvard Mit Health Sciences & Technology (1998), Independent Director at Axcella Health, Inc. (2022-2023), Independent Director at Rubius Therapeutics, Inc. (2014-2023), Director at Cobalt Biomedicine, Inc., Independent Director at Azenta, Inc. (2018-2025), Chief Medical Officer & Executive Vice President at Merck & Co., Inc. (1984-2016), Chief Medical Officer at Schering-Plough Corp., Principal at The General Hospital Corp.
(1981-1984), Senior Vice President-Academic Programs at CareGroup, Inc. (2000), President at Beth Israel Deaconess Medical Center, Inc. (1996-2003), Member-Scientific Counselors Board at National Institute of Diabetes & Digestive & Kidney Diseases, Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC, Professor at Harvard Medical School, Senior Vice President-Research at Merck Sharp & Dohme Corp.
(1992), Professor at Molecular Medicine LLC, and Dean at Tufts University School of Medicine.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from Harvard Medical School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
09/12/2024 13 042 ( 0,03% ) 704 920 $ 31/01/2025
30/06/2024 0 ( -.--% ) - $ 31/01/2025

Posizioni attive di Michael Rosenblatt

SocietàPosizioneInizio
PYC THERAPEUTICS LIMITED Direttore/Membro del Consiglio 17/03/2021
Direttore/Membro del Consiglio 25/02/2022
Direttore/Membro del Consiglio -
Consulente / Consigliere 01/01/2022
Direttore/Membro del Consiglio 01/01/2016
Direttore/Membro del Consiglio 01/01/2016
Corporate Officer/Principal 29/12/2010
Direttore/Membro del Consiglio 01/01/2016
Tutte le posizioni attive di Michael Rosenblatt

Precedenti posizioni note di Michael Rosenblatt

SocietàPosizioneFine
AZENTA, INC. Direttore/Membro del Consiglio 30/01/2025
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Michael Rosenblatt

Formazione di Michael Rosenblatt

The Trustees of Columbia University in The City of New York Undergraduate Degree
Harvard Medical School Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Rosenblatt

Relazioni

100 +

Relazioni di 1° grado

31

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
MERCK & CO., INC.

Health Technology

AZENTA, INC.

Health Services

PYC THERAPEUTICS LIMITED

Health Technology

Aziende private24

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Molecular Medicine LLC

Health Technology

Health Services

Health Technology

National Institute of Diabetes & Digestive & Kidney Diseases

Government

Health Technology

Technology Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Michael Rosenblatt